148 related articles for article (PubMed ID: 22539471)
21. Short communication: evaluation of a new rapid diagnostic test for quality assurance by kala azar elimination programme in bangladesh.
Khan MG; Alam MS; Bhuiyan AT; Jamil MA; Saha B; Islam M; Haque R; Hossain M; Jamil KM
J Parasitol Res; 2011; 2011():862475. PubMed ID: 22132308
[TBL] [Abstract][Full Text] [Related]
22. Cytokine profile in the saliva of patients with active psoriasis revealed significant upregulation of TNF-α, IFN-γ, IL-2 and downregulation of IL-10.
Sharma RK; Sharma MR; Mahendra A; Sood S; Kumar A; Sharma AK
Arch Dermatol Res; 2024 May; 316(6):289. PubMed ID: 38809371
[No Abstract] [Full Text] [Related]
23. Increased amphiregulin expression by CD4
Singh SS; Chauhan SB; Ng SS; Corvino D; de Labastida Rivera F; Engel JA; Waddell N; Mukhopadhay P; Johnston RL; Koufariotis LT; Nylen S; Prakash Singh O; Engwerda CR; Kumar R; Sundar S
Clin Transl Immunology; 2022; 11(6):e1396. PubMed ID: 35663920
[TBL] [Abstract][Full Text] [Related]
24. Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches.
Joshi S; Rawat K; Yadav NK; Kumar V; Siddiqi MI; Dube A
Front Immunol; 2014; 5():380. PubMed ID: 25202307
[TBL] [Abstract][Full Text] [Related]
25. Historical experience in the elimination of visceral leishmaniasis in the plain region of Eastern and Central China.
Guan LR; Wu ZX
Infect Dis Poverty; 2014 Mar; 3(1):10. PubMed ID: 24650707
[TBL] [Abstract][Full Text] [Related]
26. Studies on the arginase, 5'-nucleotidase and lysozyme activity by monocytes from visceral leishmaniasis patients.
Kumar P; Kumar R; Pandey H; Sundar S; Pai K
J Parasit Dis; 2012 Apr; 36(1):19-25. PubMed ID: 23542635
[TBL] [Abstract][Full Text] [Related]
27. Blood transfusion in the care of patients with visceral leishmaniasis: a review of practices in therapeutic efficacy studies.
Dahal P; Singh-Phulgenda S; Wilson J; Cota G; Ritmeijer K; Musa A; Alves F; Stepniewska K; Guerin PJ
Trans R Soc Trop Med Hyg; 2024 May; ():. PubMed ID: 38690667
[TBL] [Abstract][Full Text] [Related]
28. Cytokines and visceral leishmaniasis: a comparison of plasma cytokine profiles between the clinical forms of visceral leishmaniasis.
Costa AS; Costa GC; Aquino DM; Mendonça VR; Barral A; Barral-Netto M; Caldas Ade J
Mem Inst Oswaldo Cruz; 2012 Sep; 107(6):735-9. PubMed ID: 22990961
[TBL] [Abstract][Full Text] [Related]
29. Demographic characteristics and prevalence of asymptomatic
Yimer M; Takele Y; Yizengaw E; Nibret E; Sumova P; Volf P; Yismaw G; Alehegn M; Rowan A; Müller I; Cotton JA; Chapman LAC; Kropf P
Front Epidemiol; 2024; 4():1367387. PubMed ID: 38655403
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppressants alter the immune response associated with Glucantime
Bernardo L; Solana JC; Sánchez C; Torres A; Reyes-Cruz EY; Carrillo E; Moreno J
Front Immunol; 2023; 14():1285943. PubMed ID: 38106411
[TBL] [Abstract][Full Text] [Related]
31. Potential Biomarkers for Asymptomatic Visceral Leishmaniasis among Iraq-Deployed U.S. Military Personnel.
de Araujo FF; Lakhal-Naouar I; Koles N; Raiciulescu S; Mody R; Aronson N
Pathogens; 2023 May; 12(5):. PubMed ID: 37242376
[TBL] [Abstract][Full Text] [Related]
32. Recurrent visceral leishmaniasis relapses in HIV co-infected patients are characterized by less efficient immune responses and higher parasite load.
Takele Y; Mulaw T; Adem E; Womersley R; Kaforou M; Franssen SU; Levin M; Taylor GP; Müller I; Cotton JA; Kropf P
iScience; 2023 Feb; 26(2):105867. PubMed ID: 36685039
[TBL] [Abstract][Full Text] [Related]
33. Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation.
Takele Y; Adem E; Franssen SU; Womersley R; Kaforou M; Levin M; Müller I; Cotton JA; Kropf P
PLoS Negl Trop Dis; 2022 Jun; 16(6):e0010544. PubMed ID: 35749568
[TBL] [Abstract][Full Text] [Related]
34. T Lymphocyte Exhaustion During Human and Experimental Visceral Leishmaniasis.
Costa-Madeira JC; Trindade GB; Almeida PHP; Silva JS; Carregaro V
Front Immunol; 2022; 13():835711. PubMed ID: 35585983
[TBL] [Abstract][Full Text] [Related]
35. A Historic Review of the Role of CD4+ T-Cell Subsets in Development of the Immune Responses against Cutaneous and Visceral Leishmaniases.
Alimohmmadian MH; Ajdary S; Bahrami F
Iran Biomed J; 2022 Mar; 26(2):99-109. PubMed ID: 35090305
[TBL] [Abstract][Full Text] [Related]
36. Antibody and cytokine levels in visceral leishmaniasis patients with varied parasitemia before, during, and after treatment in patients admitted to Arba Minch General Hospital, southern Ethiopia.
Tadesse D; Abdissa A; Mekonnen M; Belay T; Hailu A
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009632. PubMed ID: 34351903
[TBL] [Abstract][Full Text] [Related]
37. A review of the leishmanin skin test: A neglected test for a neglected disease.
Carstens-Kass J; Paulini K; Lypaczewski P; Matlashewski G
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009531. PubMed ID: 34292942
[TBL] [Abstract][Full Text] [Related]
38. Evidence of Zika virus circulation in asymptomatic pregnant women in Northeast, Brazil.
Branco RCC; Brasil P; Araújo JMG; Cardoso FO; Batista ZS; Leitão VMS; da Silva MACN; de Castro LO; Valverde JG; Jeronimo SMB; Lima JA; Ribeiro da Silva R; Barbosa MDCL; Brito LMO; Xavier MAP; Nascimento MDDSB
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009412. PubMed ID: 34111119
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of In vitro and In vivo Protective Efficacy of Bauhinia variegata Against Leishmania donovani in Murine Model.
Kaur G; Chauhan K; Anand N; Kaur S
Acta Parasitol; 2021 Sep; 66(3):812-826. PubMed ID: 33528770
[TBL] [Abstract][Full Text] [Related]
40. Genetics, Transcriptomics and Meta-Taxonomics in Visceral Leishmaniasis.
Blackwell JM; Fakiola M; Singh OP
Front Cell Infect Microbiol; 2020; 10():590888. PubMed ID: 33324576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
